Riskpilot← Back to searchSign inGet full accessGillisdotter Vårdkonsult AB
ABActiveOrg 5592038540Lohäradsvägen 29Hospital activities · NACE 8610Est. 20190 employees
Revenue 2025
SEK 2M
+4% vs 2024
EBITDA margin
2.6%
-44% vs 2024
Equity ratio
16.2%
Financial strength
Net profit 2025
SEK 42K
-41% vs 2024
| Revenue | SEK 2M | +4% |
| EBITDA | SEK 51K | -44% |
| Net profit | SEK 42K | -41% |
| Total assets | SEK 3M | +15% |
| Equity | SEK 487K | +9% |
| Employees | 0 | — |
Legal name
Gillisdotter Vårdkonsult AB
Org number
5592038540
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
26 april 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet inom hälso- och sjukvård, personlig assistans, arbete samt därmed förenlig verksamhet. Företaget ska även bedriva konsultverksamhet med terapihund inom ovanstående områden samt konsultverksamhet inom hund- samt hundassistansverksamhet.
Address
Lohäradsvägen 29
Email
anna.p.gillisdotter@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | 1 957 | 2 090 | 1 916 | 1 989 |
| Staff expenses | — | −1 533 | −1 519 | −1 345 | −1 522 |
| EBITDA | 0 | 110 | 157 | 90 | 51 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 0 | 110 | 157 | 90 | 51 |
| Net financials | — | — | — | 1 | 4 |
| Profit before tax | 0 | 110 | 157 | 91 | 55 |
| Tax | — | −24 | −32 | −21 | −13 |
| Net profit | — | 87 | 124 | 70 | 42 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | — | 1 612 | 2 098 | 2 610 | 3 007 |
| Equity | — | 341 | 375 | 445 | 487 |
| Long-term debt | — | — | — | — | — |
| Short-term debt | — | 1 271 | 1 724 | 2 165 | 2 520 |
| Total debt | — | 1 271 | 1 724 | 2 165 | 2 520 |
EBITDA margin
2.6%
This company
15.8%
Market median
-84% vs market
20212025
Equity ratio
16.2%
This company
38.2%
Market median
-58% vs market
20212025
Return on equity
8.6%
This company
18.4%
Market median
-53% vs market
20212025
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
20212025
Asset turnover
0.66×
This company
1.12×
Market median
-41% vs market
20212025
Debt / equity
5.18×
This company
0.62×
Market median
-735% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-05-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gillisdotter Vårdkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Gerhard Gillisdotter | Chairman | 0 companies |
| Anna Paulina Gillisdotter | Board of Directors | 0 companies |
| Arja Hillevi Vallström | Chairman | 0 companies |